ovel high-definition transcranial grey noise stimulation (HD-tGNS) for the treatment of Major Depressive Disorder: A proof of concept study

Dirk De Ridder0 个研究点目标入组 24 人开始时间: 2021年4月29日最近更新: 2021年11月22日

适应症

试验速览

暂无简介。

•Participants with a diagnosis of MDD will be eligible to participate. To be included in the study, participants must meet all of the following inclusion criteria:
•Capable of understanding the study information and able to sign the informed consent form.
•Age between 18 to 60 years on the day of the consent.
•A score lower than three on the Maudsley Staging Method for treatment resistant depression.

•Participants who meet any of the following conditions will be excluded:
•Other mental illness
•History of neurological diseases
•History of epilepsy or seizures
•History of substance abuse,
•Previous treatment with neuromodulation (e.g. Transcranial magnetic stimulation, electroconvulsive therapy, Neurofeedback, etc.)
•Dyslipidaemia
•Cognitive impairments (dementia, post-traumatic stress disorders, Alzheimer’s disease): A total score of 24 or below on Mini-Mental State Examination
•History of uncontrolled/untreated hypertension
•Presence of any pacemaker or defibrillator
•Presence of any electronic implants or metal implant in the body (particularly head and neck)
•Recent or current pregnancy
•Note ~ Participants will be permitted to continue their medications for the duration of the trial, with the type and dosage of medication being recorded throughout the duration of the trial. However, participants with the intention of taking new medications in the next 2 months, will be excluded.

发起方

Dirk De Ridder